| P2093 | author name string | Helena Bujdáková | |
| | Lucia Černáková | |
| | Stanislava Dižová | |
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
| | The Candida albicans-specific gene EED1 encodes a key regulator of hyphal extension | Q27348786 |
| | Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors | Q28344744 |
| | Farnesol-induced apoptosis in Candida albicans | Q30487814 |
| | The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole | Q33351744 |
| | Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents | Q33689421 |
| | Farnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum | Q33913164 |
| | Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms | Q33982871 |
| | Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm | Q34079974 |
| | Farnesol-induced apoptosis in Candida albicans is mediated by Cdr1-p extrusion and depletion of intracellular glutathione | Q34113632 |
| | Enhanced production of farnesol by Candida albicans treated with four azoles | Q34142059 |
| | In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms | Q35152853 |
| | Role for cell density in antifungal drug resistance in Candida albicans biofilms | Q35878982 |
| | Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013. | Q36486984 |
| | Candida albicans biofilms: development, regulation, and molecular mechanisms | Q36880010 |
| | The metabolic basis of Candida albicans morphogenesis and quorum sensing. | Q37868078 |
| | Quorum sensing in fungi--a review | Q37977983 |
| | Recent insights into Candida albicans biofilm resistance mechanisms | Q38131290 |
| | The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans | Q38626885 |
| | Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. | Q39491534 |
| | Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule | Q39661623 |
| | Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. | Q39844899 |
| | Farnesol induces hydrogen peroxide resistance in Candida albicans yeast by inhibiting the Ras-cyclic AMP signaling pathway | Q40327252 |
| | Physiological implications of sterol biosynthesis in yeast | Q40945250 |
| | Effectiveness of the Photoactive Dye Methylene Blue versus Caspofungin on the Candida parapsilosis Biofilm in vitro and ex vivo | Q41653179 |
| | Purification and properties of cytochrome P-450-dependent 14 alpha-sterol demethylase from Candida albicans | Q41948927 |
| | Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms. | Q42111899 |
| | The impact of growth conditions on biofilm formation and the cell surface hydrophobicity in fluconazole susceptible and tolerant Candida albicans | Q42201513 |
| | Blocking of Candida albicans biofilm formation by cis-2-dodecenoic acid and trans-2-dodecenoic acid | Q42730259 |
| | Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans | Q43102358 |
| | Secretion of E,E-farnesol and biofilm formation in eight different Candida species | Q43156685 |
| | In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms | Q44405025 |
| | Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis | Q46573245 |
| | Changes in glutathione-dependent redox status and mitochondrial energetic strategies are part of the adaptive response during the filamentation process in Candida albicans | Q46867132 |
| | Effect of squalene synthase gene disruption on synthesis of polyprenols in Saccharomyces cerevisiae. | Q52531897 |
| | Anti-Candida activity of four antifungal benzothiazoles. | Q54231014 |
| | Correlation between the sterol composition of membranes and morphology in Candida albicans | Q68143494 |
| | Regulation of squalene synthetase and squalene epoxidase activities in Saccharomyces cerevisiae | Q69566477 |
| | Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations | Q70409691 |
| | The role of ERG20 gene (encoding yeast farnesyl diphosphate synthase) mutation in long dolichol formation. Molecular modeling of FPP synthase | Q73039101 |
| | Synergy, antagonism, and what the chequerboard puts between them | Q73521098 |
| | Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae | Q77784495 |
| P921 | main subject | Candida albicans | Q310443 |
| | fluconazole | Q411478 |
| | biofilm | Q467410 |
| P577 | publication date | 2017-12-12 | |
| P1433 | published in | Folia Microbiologica | Q15762225 |
| P1476 | title | The impact of farnesol in combination with fluconazole on Candida albicans biofilm: regulation of ERG20, ERG9, and ERG11 genes | |